161 related articles for article (PubMed ID: 15208331)
1. Focal adhesion kinase (FAK)-dependent regulation of S-phase kinase-associated protein-2 (Skp-2) stability. A novel mechanism regulating smooth muscle cell proliferation.
Bond M; Sala-Newby GB; Newby AC
J Biol Chem; 2004 Sep; 279(36):37304-10. PubMed ID: 15208331
[TBL] [Abstract][Full Text] [Related]
2. p27Kip1 and cyclin D1 are necessary for focal adhesion kinase regulation of cell cycle progression in glioblastoma cells propagated in vitro and in vivo in the scid mouse brain.
Ding Q; Grammer JR; Nelson MA; Guan JL; Stewart JE; Gladson CL
J Biol Chem; 2005 Feb; 280(8):6802-15. PubMed ID: 15557280
[TBL] [Abstract][Full Text] [Related]
3. Focal adhesion kinase controls cellular levels of p27/Kip1 and p21/Cip1 through Skp2-dependent and -independent mechanisms.
Bryant P; Zheng Q; Pumiglia K
Mol Cell Biol; 2006 Jun; 26(11):4201-13. PubMed ID: 16705171
[TBL] [Abstract][Full Text] [Related]
4. 3-Hydroxy-3-methylglutaryl-CoA reductase inhibitors attenuate vascular smooth muscle proliferation by preventing rho GTPase-induced down-regulation of p27(Kip1).
Laufs U; Marra D; Node K; Liao JK
J Biol Chem; 1999 Jul; 274(31):21926-31. PubMed ID: 10419514
[TBL] [Abstract][Full Text] [Related]
5. p27(Kip1) is important in modulating pulmonary artery smooth muscle cell proliferation.
Fouty BW; Grimison B; Fagan KA; Le Cras TD; Harral JW; Hoedt-Miller M; Sclafani RA; Rodman DM
Am J Respir Cell Mol Biol; 2001 Nov; 25(5):652-8. PubMed ID: 11713109
[TBL] [Abstract][Full Text] [Related]
6. Role for p27(Kip1) in Vascular Smooth Muscle Cell Migration.
Sun J; Marx SO; Chen HJ; Poon M; Marks AR; Rabbani LE
Circulation; 2001 Jun; 103(24):2967-72. PubMed ID: 11413088
[TBL] [Abstract][Full Text] [Related]
7. Perlecan-induced suppression of smooth muscle cell proliferation is mediated through increased activity of the tumor suppressor PTEN.
Garl PJ; Wenzlau JM; Walker HA; Whitelock JM; Costell M; Weiser-Evans MC
Circ Res; 2004 Feb; 94(2):175-83. PubMed ID: 14656929
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of vascular smooth muscle cell proliferation by sodium salicylate mediated by upregulation of p21(Waf1) and p27(Kip1).
Marra DE; Simoncini T; Liao JK
Circulation; 2000 Oct; 102(17):2124-30. PubMed ID: 11044431
[TBL] [Abstract][Full Text] [Related]
9. Focal adhesion kinase facilitates platelet-derived growth factor-BB-stimulated ERK2 activation required for chemotaxis migration of vascular smooth muscle cells.
Hauck CR; Hsia DA; Schlaepfer DD
J Biol Chem; 2000 Dec; 275(52):41092-9. PubMed ID: 10998418
[TBL] [Abstract][Full Text] [Related]
10. Selective expression of an endogenous inhibitor of FAK regulates proliferation and migration of vascular smooth muscle cells.
Taylor JM; Mack CP; Nolan K; Regan CP; Owens GK; Parsons JT
Mol Cell Biol; 2001 Mar; 21(5):1565-72. PubMed ID: 11238893
[TBL] [Abstract][Full Text] [Related]
11. FAK in the nucleus prevents VSMC proliferation by promoting p27 and p21 expression via Skp2 degradation.
Jeong K; Murphy JM; Ahn EE; Lim SS
Cardiovasc Res; 2022 Mar; 118(4):1150-1163. PubMed ID: 33839758
[TBL] [Abstract][Full Text] [Related]
12. PDGF-BB-mediated activation of CREB in vascular smooth muscle cells alters cell cycling via Rb, FoxO1 and p27
Perrault R; Molnar P; Poole J; Zahradka P
Exp Cell Res; 2021 Jul; 404(1):112612. PubMed ID: 33895117
[TBL] [Abstract][Full Text] [Related]
13. An endogenous inhibitor of focal adhesion kinase blocks Rac1/JNK but not Ras/ERK-dependent signaling in vascular smooth muscle cells.
Sundberg LJ; Galante LM; Bill HM; Mack CP; Taylor JM
J Biol Chem; 2003 Aug; 278(32):29783-91. PubMed ID: 12782622
[TBL] [Abstract][Full Text] [Related]
14. Perlecan up-regulation of FRNK suppresses smooth muscle cell proliferation via inhibition of FAK signaling.
Walker HA; Whitelock JM; Garl PJ; Nemenoff RA; Stenmark KR; Weiser-Evans MC
Mol Biol Cell; 2003 May; 14(5):1941-52. PubMed ID: 12802066
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of the cyclin-dependent kinase inhibitors p27(Kip1), p21(Cip1), and p16(Ink4) on vascular smooth muscle cell proliferation.
Tanner FC; Boehm M; Akyürek LM; San H; Yang ZY; Tashiro J; Nabel GJ; Nabel EG
Circulation; 2000 May; 101(17):2022-5. PubMed ID: 10790340
[TBL] [Abstract][Full Text] [Related]
16. p27(Kip1) stabilization and G(1) arrest by 1,25-dihydroxyvitamin D(3) in ovarian cancer cells mediated through down-regulation of cyclin E/cyclin-dependent kinase 2 and Skp1-Cullin-F-box protein/Skp2 ubiquitin ligase.
Li P; Li C; Zhao X; Zhang X; Nicosia SV; Bai W
J Biol Chem; 2004 Jun; 279(24):25260-7. PubMed ID: 15075339
[TBL] [Abstract][Full Text] [Related]
17. Identification of a novel redox-sensitive gene, Id3, which mediates angiotensin II-induced cell growth.
Mueller C; Baudler S; Welzel H; Böhm M; Nickenig G
Circulation; 2002 May; 105(20):2423-8. PubMed ID: 12021231
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of F-Box protein p45(SKP2) expression and stabilization of cyclin-dependent kinase inhibitor p27(KIP1) in vitamin D analog-treated cancer cells.
Lin R; Wang TT; Miller WH; White JH
Endocrinology; 2003 Mar; 144(3):749-53. PubMed ID: 12586749
[TBL] [Abstract][Full Text] [Related]
19. BCR/ABL regulates expression of the cyclin-dependent kinase inhibitor p27Kip1 through the phosphatidylinositol 3-Kinase/AKT pathway.
Gesbert F; Sellers WR; Signoretti S; Loda M; Griffin JD
J Biol Chem; 2000 Dec; 275(50):39223-30. PubMed ID: 11010972
[TBL] [Abstract][Full Text] [Related]
20. A non-thiazolidinedione partial peroxisome proliferator-activated receptor gamma ligand inhibits vascular smooth muscle cell growth.
Bruemmer D; Berger JP; Liu J; Kintscher U; Wakino S; Fleck E; Moller DE; Law RE
Eur J Pharmacol; 2003 Apr; 466(3):225-34. PubMed ID: 12694805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
